Researchers from University Hospital, Division of Gastroenterology describe findings in hepatitis C virus therapy

Research findings, "Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study," are discussed in a new report. In this recently published article, scientists in Germany conducted a study "To investigate the use of high dose consensus-interferon in combination with ribavirin in former iv drug users infected with hepatitis C. We started, before pegylated (PEG)-interferons were available, an open-label study to investigate the efficacy and tolerability of high dose induction therapy with consensus interferon (CIFN) and ribavirin in treatment of naiive patients with chronic hepatitis...

Want to see the full article?

• Purchase this article for only $3.00